Cell-Free Fetal DNA Testing
Customize your policy alerts
Sign up for Colorado Rocky Mountain Health Plans Policy CS085.AH alerts
Get alerted when Policy CS085.AH changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of cell-free fetal DNA testing using maternal plasma during pregnancy, including fetal RhD genotyping and screening for selected fetal aneuploidies. It applies to providers seeking coverage for members, subject to applicable benefit, legal, and contractual requirements.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.